VKTX
Viking Therapeutics, Inc.
Stock
$29.94−0.57 (−1.87%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | −$418M | −$279M | −$88M | −$73M | −$48M | −$48M | −$22M | −$25M | −$19M | −$15M | −$11M | −$8.7M | −$1.6M |
| Stock-based compensation | $37M | $41M | $30M | $17M | $8.7M | $6.1M | $5.8M | $3.7M | $2.6M | $1.5M | $1.8M | $2.6M | $6K |
| Buybacks | — | — | — | — | $6.8M | — | — | — | — | — | $229 | $38 | $2 |